SELLAS Life Sciences Group, Inc. Warrants and Rights Outstanding
SELLAS Life Sciences Group, Inc. (SLS) had Warrants and Rights Outstanding of $11.88 million as of 2011-06-30, per its 10-Q filed 2011-08-15.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2011-08-15
- 2011-06-30: Warrants and Rights Outstanding $11.88M.
- 2010-12-31: Warrants and Rights Outstanding $3.14M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2011-06-30 | $11.88M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $3.14M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |